home / stock / wve / wve news

WVE News and Press, Wave Life Sciences Ltd.

Stock Information
Company Name: Wave Life Sciences Ltd.
Stock Symbol: WVE
Market: NASDAQ
Website: wavelifesciences.com
Menu
WVE WVE Quote WVE Short WVE News WVE Articles WVE Message Board
Get WVE Alerts

News, Short Squeeze, Breakout and More Instantly...
WVE - Wave jumps on trial data for Huntington's disease therapy

2024-06-25 08:13:12 ET More on Takeda, Wave Life Sciences, etc. Takeda: Strong Growth Catalysts And Maturing Pipeline Continue To Limit Downside Risk Takeda Pharmaceutical Company Limited (TAK) Fiscal Year 2023 Earnings Call Transcript Wave Life Sciences Ltd. (WVE) Q...
WVE - Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical Demonstration of Allele-Selective Mutant Huntingtin Lowering in Huntington's Disease

Statistically significant, potent, and durable allele-selective silencing: 46% mean reduction in CSF mutant huntingtin (mHTT) protein compared to placebo, preservation of wild-type huntingtin (wtHTT) protein, and generally safe and well-tolerated profile achieved in 30 mg multidose cohort ...

WVE - Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA Editing

Presentation at the Obesity & Weight Loss Drug Development Summit to review Real World Evidence for the GLP-1 class and the opportunity for Wave’s INHBE program as a best-in-class approach for obesity designed to induce fat burning and preserve muscle mass with once or twice-annual sub...

WVE - Alnylam, Pliant among stocks yet to face Q2 catalysts: Wells Fargo

2024-06-07 15:09:58 ET More on Alnylam, Pliant, etc. Upcoming Pivotal HELIOS-B Data Looms Large For Alnylam's Valuation Alnylam Pharmaceuticals, Inc. (ALNY) Q1 2024 Earnings Call Transcript Alnylam Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation ...
WVE - Wave Life Sciences to Present at 2024 Jefferies Global Healthcare Conference

CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is...

WVE - PTC Therapeutics rallies 18% on EU authorization update for Translarna

2024-05-20 09:58:45 ET More on PTC Therapeutics PTC Therapeutics: Multiple Regulatory Submissions Along With Data Cuts PTC Therapeutics, Inc. (PTCT) Q1 2024 Earnings Call Transcript PTC Therapeutics, Inc. (PTCT) Q4 2023 Earnings Call Transcript PTC Therapeuti...

WVE - Wells Fargo starts Wave Life Sciences at buy, cites valuation

2024-05-15 14:11:35 ET More on Wave Life Sciences Wave Life Sciences Ltd. (WVE) Q1 2024 Earnings Call Transcript Wave Life Sciences' Weighty Ambition: Carving Out Obesity Niche Wave Life Sciences Ltd. (WVE) Q4 2023 Earnings Call Transcript Wave Life Sciences ...
WVE - WVE Price Target Alert: $11.00. Issued by Wells Fargo

2024-05-15 07:00:05 ET Tiago Fauth from Wells Fargo issued a price target of $11.00 for WVE on 2024-05-15 05:53:00. The adjusted price target was set to $11.00. At the time of the announcement, WVE was trading at $5.84. WVE currently trades -24.58% versus its 52 week hig...

WVE - HHS panel to vote in Nov. on DMD screening for newborns

2024-05-09 18:44:45 ET More on Catalyst Pharmaceuticals, Sarepta Therapeutics, etc. Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2024 Earnings Call Transcript Sarepta Therapeutics, Inc. (SRPT) Q1 2024 Earnings Call Transcript Sarepta Therapeutics: Growth Trajectory Alter...

WVE - Wave Life Sciences Ltd. (WVE) Q1 2024 Earnings Call Transcript

2024-05-09 14:53:01 ET Wave Life Sciences Ltd. (WVE) Q1 2024 Earnings Conference Call May 09, 2024 08:30 AM ET Company Participants Kate Rausch - Vice President, Investor Relations & Corporate Affairs Paul Bolno - President & Chief Executive Officer Anne-...
Next 10